Genentech, a pioneer in daring DNA research, goes public
The list of products by Genentech, a four-year-old San Francisco-based firm, reads like a cornucopia of blessings for mankind. It includes a hormone that may stimulate human growth, mass-produced human insulin that could reduce the cost of treating diabetes, and interferon (TIME, March 31), which may be used to treat everything from cancer to the common cold. Shares of Genentech are expected to go on sale soon on the over-the-counter market, and investors are queuing up to buy what some believe will be one of...
To continue reading:
or
Log-In